Animal Health Market Trends, Demand and Forecast 2034
- Bharat Jagtap
- 3 hours ago
- 5 min read
The global animal health market is experiencing significant growth as veterinary healthcare becomes increasingly important for food security, public health protection, and companion animal well-being. Animal health encompasses pharmaceuticals, vaccines, diagnostics, and nutritional products designed to prevent, detect, and manage diseases in livestock and companion animals. Rising pet ownership, increasing consumption of animal-derived protein, growing awareness of zoonotic diseases, and expanding veterinary infrastructure are supporting market growth. In addition, technological advancements in diagnostics, biologics, digital health monitoring, and preventive healthcare solutions are transforming the veterinary healthcare landscape.
Market Size and Forecast
The global animal health market size was valued at USD 70.16 billion in 2025 and is projected to grow from USD 78.27 billion in 2026 to USD 187.79 billion by 2034, exhibiting a CAGR of 11.56% during the forecast period. North America dominated the global market with a 34.02% share in 2025. The market is being driven by rising pet adoption, increasing prevalence of zoonotic diseases, growing demand for protein-rich food, and continuous innovation in veterinary medicines and diagnostics.
For detailed market insights, visit the Animal Health Market Report.
Why is the Animal Health Market Growing Rapidly?
The increasing incidence of zoonotic diseases and growing awareness regarding animal welfare are major drivers supporting market growth. Governments, livestock producers, and pet owners are investing more in preventive healthcare solutions to improve animal health and reduce disease transmission risks.
The rising adoption of companion animals worldwide is another significant growth factor. Pets are increasingly considered family members, resulting in higher spending on veterinary care, diagnostics, chronic disease management, and wellness programs. Additionally, rising global demand for animal-derived protein is encouraging livestock producers to invest in preventive healthcare programs, vaccinations, and disease monitoring systems to improve productivity and food safety.
Key Market Trends Shaping Industry Growth
Growing Pet Humanization and Companion Animal Care
Pet ownership continues to rise globally, accompanied by increasing demand for advanced veterinary services. Pet parents are increasingly seeking specialized treatments, preventive care, chronic disease management, and premium healthcare products that mirror human healthcare standards.
Expansion of Preventive Healthcare Programs
Preventive care is becoming a central focus within the industry. Vaccines, diagnostics, parasite control products, and wellness programs are gaining prominence as stakeholders prioritize disease prevention over reactive treatment approaches.
Digitalization and Advanced Diagnostics
The adoption of digital health technologies, remote monitoring tools, practice management software, molecular diagnostics, and rapid testing platforms is improving veterinary decision-making and enabling earlier disease detection. These innovations are supporting data-driven animal healthcare management.
Market Segmentation Analysis
Leading Product Segment
The drugs segment accounted for the largest market share and is projected to maintain its dominance throughout the forecast period. Drugs represented 45.5% of the market in 2025 due to their widespread use in preventing, controlling, and treating animal diseases across both livestock and companion animals. Antiparasitics, anti-infectives, and anti-inflammatory medications continue to drive segment growth.
Fastest Growing Product Segment
The diagnostics segment is projected to witness the fastest growth during the forecast period. Increasing adoption of molecular diagnostics, rapid testing solutions, imaging technologies, and precision veterinary medicine is supporting segment expansion.
Leading Animal Segment
Companion animals held the largest market share in 2025. Rising pet ownership, increasing emotional attachment between owners and pets, and growing demand for advanced healthcare services are driving segment growth. Companion animals are expected to continue expanding rapidly throughout the forecast period.
Fastest Growing Animal Segment
Companion animals are also expected to register the fastest growth due to increasing pet adoption among urban populations, elderly individuals, and households seeking companionship. Higher spending on pet healthcare further supports market expansion.
Leading End-user Segment
Veterinary hospitals and clinics accounted for the largest market share. These facilities serve as the primary access points for diagnosis, treatment, preventive care, and chronic disease management. Rising veterinary visits and expanded service offerings continue to support segment growth.
Fastest Growing End-user Segment
Diagnostic centers are projected to grow rapidly due to increasing awareness regarding preventive care, growing adoption of advanced diagnostic technologies, and rising demand for specialized testing services.
Regional Insights
North America Leads the Global Market
North America generated USD 14.12 billion in revenue in 2025 and remained the largest regional market. Advanced veterinary infrastructure, high pet ownership rates, growing companion animal healthcare spending, and increasing incidence of zoonotic diseases continue to support market leadership.
United States Maintains Regional Dominance
The U.S. leads the regional market due to large-scale livestock operations, a highly developed companion animal ecosystem, growing pet insurance adoption, and significant investments in veterinary innovation. The country also serves as a major hub for animal health research and product development.
Europe Shows Consistent Growth
Europe holds the second-largest market position globally. Strong animal welfare regulations, preventive healthcare adoption, disease surveillance programs, and antimicrobial stewardship initiatives are supporting market expansion. Germany and the U.K. remain key contributors to regional growth.
Asia Pacific Emerges as a High-Growth Region
Asia Pacific is expected to witness strong growth driven by expanding veterinary infrastructure, increasing livestock populations, rising protein consumption, and growing companion animal ownership. Countries such as China, Japan, and India are investing heavily in veterinary healthcare modernization.
Latin America and Middle East & Africa Offer Growth Opportunities
Both regions are experiencing increasing demand for animal health products due to expanding livestock industries, food security initiatives, and growing veterinary awareness. Improvements in veterinary infrastructure and disease management programs are expected to create significant future opportunities.
Competitive Landscape
The animal health market is characterized by the presence of leading pharmaceutical, biotechnology, and diagnostics companies competing through innovation, product portfolio expansion, acquisitions, partnerships, and geographic expansion. Market participants are increasingly focusing on biologics, diagnostics, precision medicine, and integrated healthcare solutions to strengthen their competitive positions. Strategic collaborations and investments in preventive healthcare technologies remain key growth strategies.
Major Companies Operating in the Market Include:
Zoetis
Intervet International B.V.
Elanco
Ceva
Virbac
Merck & Co., Inc.
Novartis AG
Emergent BioSolutions, Inc.
CSL Limited
IDEXX Laboratories, Inc.
Recent Industry Developments
Zoetis Expanded Companion Animal Portfolio
In March 2025, Zoetis launched a next-generation monoclonal antibody therapy for chronic pain management in dogs, utilizing advanced biologics engineering to improve treatment outcomes and compliance.
Elanco Strengthened Diagnostic Capabilities
In January 2025, Elanco completed the acquisition of a specialty diagnostics company, enhancing its disease detection portfolio through rapid immunoassay platforms and cloud-enabled diagnostic workflows.
Boehringer Ingelheim Introduced Advanced Livestock Vaccine
In October 2024, Boehringer Ingelheim launched a recombinant multivalent vaccine designed to improve livestock disease prevention while reducing administration frequency in commercial farming operations.
Merck Animal Health Expanded Digital Monitoring Solutions
In July 2024, Merck Animal Health introduced a digital herd health monitoring platform combining wearable sensors and predictive analytics for disease detection and productivity management.
Future Outlook
The future of the animal health market remains highly promising as veterinary healthcare increasingly embraces digitalization, precision medicine, preventive care, and advanced diagnostics. Growing pet ownership, rising demand for protein-rich food, expanding disease surveillance programs, and technological innovation are expected to create substantial growth opportunities. The integration of IoT-enabled monitoring devices, artificial intelligence, biologics, and molecular diagnostics will further enhance veterinary healthcare delivery. Public-private partnerships and government-led animal health initiatives are also expected to support long-term market development through 2034.
Comments